Brief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
28/05/2025 14:26
May 28 (Reuters) - BetterLife Pharma Inc BETR.CD: BETTERLIFE PHARMA PROVIDES SCIENTIFIC UPDATE ON NEUROPLASTOGENIC ACTIVITY OF BETR-001 BETTERLIFE PHARMA INC - BETR-001 IND FILING AND HUMAN TRIALS PROJECTED FOR H1 2026 Source text: ID:nGNX7jl72j Further company coverage: BETR.CD ((Reuters.Briefs@thomsonreuters.com;))
Recent news on BetterLife Pharma
See all newsBrief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
Brief: Betterlife Pharma Advanced In IND-enabling Studies For BETR-001
Brief: BetterLife Announces Closing Of $1.168 Million Convertible Debentures To Further Advance IND-Enabling Studies Of Its Non-Hallucinogenic LSD-Based Drug Candidate BETR-001
Brief: Omineca Announces $2 Mln Brokered Financing Of Flow-Through Units
Brief: Betterlife Announces Pricing Of Proposed Offering Of Units